Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : biotech fireworks -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (553)	1/7/2003 12:28:55 PM
From: Jibacoa	Respond to of 7424

GNSC Is up 23.5% on volume of 120,940 (almost 3x its daily average)after it announced that it has licensed its HAP Technology to MLNM. The agreement is "non-exclusive, multi-year" and MLNM will pay GNSC an undetermined amount of "license fees".<g>(For the 9Ms ended last Sept. GNSC's "license fees" from its HAP Tech. increased more than 70%) Insiders fold more than 35% and there have been some insider and institutional buying. It has been selling around 0.7 of book and has close to $1.60 in cash/share. The stock hasn't closed its early up-gap.<g> siliconinvestor.com Bernard

To: Jibacoa who wrote (553)	1/7/2003 12:28:59 PM
From: JMarcus	Read Replies (1) \| Respond to of 7424

DOR also just announced that <<it has executed an exclusive option with the University of Texas Southwestern Medical Center (UT Southwestern) in Dallas to license patent applications pending in the United States and elsewhere pertaining to the use of novel recombinant ricin A chain mutants as vaccines to protect against aerosolized ricin. The exclusive option covers the development of intranasal, oral and inhalable vaccines that can be developed using the proprietary non-toxic mutants of ricin. Ricin is the second most potent toxin known to man. It could be deployed as a weapon by aerosolization, and there is no effective antidote or vaccine approved for human use. Ricin is described by the Centers for Disease Control and Prevention (CDC) as a category B biological agent that could be used as bioterrorist weapons. Lung damage caused by inhalation of ricin toxin is quick and irreversible. Even relatively small-scale use of ricin by terrorists has the capacity to cause widespread disruption and huge expenditures of resources to diagnose and treat ricin exposure and to clean up contamination. >> Marc